JPS5946244A - Hydroxamic acid derivative and its preparation - Google Patents
Hydroxamic acid derivative and its preparationInfo
- Publication number
- JPS5946244A JPS5946244A JP57157049A JP15704982A JPS5946244A JP S5946244 A JPS5946244 A JP S5946244A JP 57157049 A JP57157049 A JP 57157049A JP 15704982 A JP15704982 A JP 15704982A JP S5946244 A JPS5946244 A JP S5946244A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- phenyl
- lower alkyl
- pyrrolyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002253 acid Substances 0.000 title claims abstract description 16
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 10
- 125000000168 pyrrolyl group Chemical group 0.000 claims abstract description 6
- 125000000335 thiazolyl group Chemical group 0.000 claims abstract description 6
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 125000005843 halogen group Chemical group 0.000 claims abstract description 5
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 4
- 229910052736 halogen Inorganic materials 0.000 claims abstract 2
- -1 chenyl group Chemical group 0.000 claims description 6
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims description 2
- 241000251730 Chondrichthyes Species 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003513 alkali Substances 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 5
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003904 antiprotozoal agent Substances 0.000 abstract description 4
- 150000001733 carboxylic acid esters Chemical class 0.000 abstract description 4
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 239000003716 antitrichomonal agent Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- IFIHPUNKYYXTLJ-UHFFFAOYSA-N n,6-dihydroxy-6-phenylhexanamide Chemical compound ONC(=O)CCCCC(O)C1=CC=CC=C1 IFIHPUNKYYXTLJ-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
本発明は一般式【1〕
AB (CH2)n C0NHOH(IL〔式中、
AはRXmを示しくここ一7? Rはフェニル基、ピロ
リルμ、チェニル基、イミグゾリル基およびチアゾリル
基を示し、Xはハロゲン原子、低級アルキル基、低級ア
ルコキシ基および二1a基を示し、・rnは0,1ま)
こは2苓示し、 rr1個のx(J同一ψたは異なるこ
とができる。)、Bは−CHOH−、−CH−、−0−
および−〇〇−を示し、nlj:2〜10のatを示す
。〕゛C表されるヒドロキサム酸誘導体およびその製油
法に関する。Detailed Description of the Invention The present invention is based on the general formula [1] AB (CH2)n C0NHOH(IL [wherein,
A stands for RXm. R represents a phenyl group, pyrrolyl μ, chenyl group, imigzolyl group, or thiazolyl group;
This shows two characters, rr1 x (J can be the same ψ or different), B is -CHOH-, -CH-, -0-
and -〇〇-, and nlj: at of 2 to 10 is shown. ] The present invention relates to a hydroxamic acid derivative represented by C and a method for producing oil thereof.
本発明によれば一般式(1)で表されるヒドロ+号、Z
b u誘導体は一般式〔2〕
AB (CHJL)n C0OR[’2]〔式中、Aは
RXmを示しくここでRはフェニル基、ピロリル基、チ
ェニル基、イミダゾリル基およびチアゾリル基を示し、
Xはハロゲン原子。According to the present invention, hydro+, Z, represented by general formula (1)
The b u derivative has the general formula [2] AB (CHJL)n C0OR['2] [wherein A represents RXm, and R represents a phenyl group, a pyrrolyl group, a chenyl group, an imidazolyl group, and a thiazolyl group,
X is a halogen atom.
低級アルキル基、低級アルコキシ基およびニトロ基を示
し1mは0.1または2を示し5m個のXは同一または
異なることができる。)、Bは−CHOH−、−CH−
、−0−および−〇〇−を示し、nは2〜10の整数を
示し、Rは低級アルキル基を示I−0〕′C表される゛
カルボ二ノ酸エステルとヒドロキシアミノとを反応ざυ
ることにより製fMすることができる。It represents a lower alkyl group, a lower alkoxy group and a nitro group, 1m represents 0.1 or 2, and 5m X's can be the same or different. ), B is -CHOH-, -CH-
, -0- and -〇〇-, n represents an integer from 2 to 10, and R represents a lower alkyl group. υ
By doing so, fM can be produced.
さらに詳しくは、有lJ iU &v中てヒドロキシア
ミン塩をアルカリで熟理し/こあと、一般式〔2〕で表
されるカルボン酸エステルを加え、 Vd拌下、室温で
30分乃至3晴間反応させる。ヒ1゛ロキシアミンの塩
としては1例λば塩酸塩が好ましく、有機溶媒としては
とくに限定されないが低級アルコール、例えばエタノー
ルが好′正しく、アルカリとしては金属アルカリ、例え
ば水酸化カリウム、水酸化ナトリウム、ノ)・リウムメ
チラートなどかまい。使用するヒ1′ロキシアミュ/塩
酸塩はカルボン酸エステルに対して1乃至3倍当用、ア
ルカリの−はカルボン酸エステルに2・1して2乃至6
倍当−が好゛ましい。反応終了後目的物であるヒドロキ
サムU誘導体を単離するには、副生し/こ無機物を除去
したあと溶媒をパル留去し、冷水を加えて贋拌しながら
希塩酸でp H4〜4.5 に調整し、目的化合物を酢
酸エチル、クロロホルム、塩化メチレンなどの通常の有
機溶媒で抽出するか、又は1^nが析出する場合にほろ
別することによフて@易に得ることができる。本発明化
合物であるヒドロキサノ、6a誘導体は強酸性条件下、
又は加熱条件下で不安定であるので反応及び後処理模作
は、温度は10℃以下i’、pHは4以上の条件下C行
うことが好すしい。More specifically, the hydroxyamine salt is digested with an alkali in an aqueous solution, then the carboxylic acid ester represented by the general formula [2] is added, and the reaction is carried out at room temperature for 30 minutes to 3 days under stirring at Vd. let One example of the salt of hydroxyamine is hydrochloride, and the organic solvent is not particularly limited, but lower alcohols such as ethanol are preferable, and the alkali is metal alkali such as potassium hydroxide, sodium hydroxide,・Rium methylate etc. are fine. The amount of H1'roxyam/hydrochloride used is 1 to 3 times as much as the carboxylic ester, and the - of the alkali is 2 to 6 times the amount of the carboxylic ester.
Double weight is preferable. After the completion of the reaction, to isolate the desired hydroxam U derivative, remove the by-products and inorganic substances, remove the solvent by distillation, add cold water, and dilute with diluted hydrochloric acid while stirring to pH 4 to 4.5. The target compound can be easily obtained by extracting it with a common organic solvent such as ethyl acetate, chloroform, or methylene chloride, or by breaking it apart if 1^n precipitates. The hydroxano, 6a derivative, which is a compound of the present invention, is prepared under strongly acidic conditions.
Since it is unstable under heating conditions, the reaction and post-treatment are preferably carried out at a temperature of 10° C. or lower i' and a pH of 4 or higher.
本発明の一般式〔1〕で表されるヒドロキサム酸誘導体
は抗原虫剤1例えば抗トリコモナス剤として、又、抗原
虫剤の中間体として価イ6がある。The hydroxamic acid derivative represented by the general formula [1] of the present invention can be used as an antiprotozoal agent 1, such as an anti-trichomoniacal agent, or as an intermediate for an antiprotozoal agent.
本発明に係るヒl’ a+サム酸銹導体としては第1表
に示す化合物が挙げられるが本発明はこれらによフて限
定されるものではない。The compounds shown in Table 1 may be mentioned as the HI' a + samic acid salt conductors according to the present invention, but the present invention is not limited thereto.
」」−表一
弐: AB CCFIユ)’n C0NHOHt、:
おイテA B
nフェニル
Co 24−クロロフェニル
43−ブロモフェニル
63−メ1キシフェニル
42−エチルフェニ
ル 53−二トロフ
Iニル 72.4−
ジクロロフェニル 52
.4−ジメトキシンlニル
52−チェニル
62−(5−クロロナエニノリ
4A
B2−(5−メチルチェニル)
CO52−(5−エチルチェニル)
72−(5−メチルピロリル
) 55−イミダゾリル
85−(2−エ
チル・イミダゾリル) 57
エニルC,HOI(2
+0
4−クロロフェニル
44−ブロモフェニル
64−フロロフェニル
5A
B5−71キソフエニル
CHOH44−メチルフェニル
54−メチルフェニル
63−二10フェニル
1?4−ジメチル
アミノフェニル 53.4−
ジクロロフェニル 44−
クロロ−2−メチルフェニル 3
4−クロロ−2,−二i口フェニル
52−チェニル
8”2−(5−クロロフェニル)
42−(5−メチルチェニル)
52−ピロリル
71−ピロリル
52−(5−メ
チルピロリル) 55−・
イミダゾリル 8
5−(2−メチルイミダゾリル)
5A
B5−(2−クロロイミダゾリル)
CHOH65−(2−ニトロイミダゾリル)
5フエニル
02フエニル
3鳴−クロロフェニル
52−ブロモフェニル
43−メ)キンフェニル
74−工1キシフ
ェール 63.4−ジ
クロロフェニル 32.
4−ジメトキシフェニル
54−クロロ−2−メチルフェニル
64− (2−メチル−5−二トロイミダゾリル
)〃55−(2−メチルイミダゾリル)
3A
B nフェニル
C11,24−クロロフェニル
44Fニトロフエニル
54−工1キシフェニ
ル 94−ジメチルア
ミノ2エニル 82.4−ジ
クロロフェニル 42−(
5−メチルチェニル) 4
2−チェニル
72−(5−エチルチェニル)
41−ピロリル
5l−(5−メチルピロリル)
42−(1−メチルピロリル
) 6l−(2−メチル−
5−二トaフェニル) 21−(2
−メチルイミダゾリル) 41
−イミダゾリル
71〔1
つぎに1本発明化合物について実施例を挙げてさらに詳
細に説明するが、:4:発明はこれらにぼって限定され
るものではない。""-Table 12: AB CCFIU)'n C0NHOHt,:
Oite A B
n phenyl
Co24-chlorophenyl
43-Bromophenyl
63-Me1xyphenyl 42-ethylphenyl 53-nitrophinyl 72.4-
Dichlorophenyl 52
.. 4-dimethoxinyl
52-chenyl
62-(5-chloronaeninori)
4A
B2-(5-methylchenyl)
CO52-(5-ethylchenyl)
72-(5-methylpyrrolyl) 55-imidazolyl
85-(2-ethyl imidazolyl) 57
enyl C, HOI (2 +0 4-chlorophenyl
44-Bromophenyl
64-fluorophenyl
5A
B5-71xophenyl
CHOH44-methylphenyl
54-methylphenyl
63-210 phenyl 1?4-dimethylaminophenyl 53.4-
Dichlorophenyl 44-
Chloro-2-methylphenyl 3
4-chloro-2,-bi-phenyl
52-chenyl
8”2-(5-chlorophenyl)
42-(5-methylchenyl)
52-pyrrolyl
71-pyrrolyl
52-(5-methylpyrrolyl) 55-
Imidazolyl 8
5-(2-methylimidazolyl)
5A
B5-(2-chloroimidazolyl)
CHOH65-(2-nitroimidazolyl)
5 phenyl
02 phenyl
3-chlorophenyl
52-Bromophenyl
43-Me)quinphenyl 74-Me)xyphenol 63.4-Dichlorophenyl 32.
4-dimethoxyphenyl
54-chloro-2-methylphenyl
64- (2-methyl-5-nitroimidazolyl) 55-(2-methylimidazolyl)
3A
B n phenyl
C11,24-chlorophenyl
44F Nitrophenyl
54-1-xyphenyl 94-dimethylamino-2-enyl 82.4-dichlorophenyl 42-(
5-methylchenyl) 4
2-chenyl
72-(5-ethylchenyl)
41-pyrrolyl
5l-(5-methylpyrrolyl)
42-(1-methylpyrrolyl) 6l-(2-methyl-
5-di-a-phenyl) 21-(2
-methylimidazolyl) 41
-imidazolyl
71 [1] Next, the compound of the present invention will be explained in more detail with reference to Examples, but: 4: The invention is not limited thereto.
実施例1
7−(4−ジメチルアミノフェニル)
−7−′A+ソヘプタノヒドロキサム6a−T−9/
−ル2 Q rn I 中にヒドロ+ンアミンjlf塩
r1.3gを縣濁し、窒素賞Im下3〜5℃にて激しく
撹拌しなからすlリウムメナラー10.48gを加え/
こ。1峙lit攪拌後、7−(4−ジメチルアミノフェ
ニル)−7−オキツヘブタン酸工Jル0.43gを加え
て室IBにて2時間攪拌した。つぎにエタノールを大部
分留去してから酢酸エチル。Example 1 7-(4-dimethylaminophenyl)-7-'A+soheptanohydroxam 6a-T-9/
- Suspend 1.3 g of hydroamine jlf salt in Q rn I, stir vigorously at 3-5°C under nitrogen, and add 10.48 g of chlorine menal.
child. After stirring for 1 hour, 0.43 g of 7-(4-dimethylaminophenyl)-7-oxhebutanoic acid was added, and the mixture was stirred in room IB for 2 hours. Next, most of the ethanol is distilled off and then ethyl acetate is added.
冷水をそれぞれ30m!づつ加えて激しく攪拌した。有
機層を除去し水層を希塩酸でp H4−ν4゜5に調整
すると白濁した。白濁しにノ夜に酢酸エチル50m1を
加えて激しく攪拌した。有4afmを無水4R酸カトリ
ウムで乾憧後、溶媒を留去し乾憎して褐邑の粘ちり・う
な液体150mgを得た。30m of cold water each! Add them one by one and stir vigorously. The organic layer was removed, and the aqueous layer was adjusted to pH 4-ν4°5 with dilute hydrochloric acid, which turned cloudy. To the cloudy mixture, 50 ml of ethyl acetate was added and stirred vigorously. After drying the 4afm with anhydrous 4R potassium acid, the solvent was distilled off and dried to obtain 150 mg of a sticky eel liquid.
NMR(CDC13); δ
1jO(In 、611 ) 、 2.20 (
t 、2N )2.97 (t 、211 )
、2.[i9 (s 、611 )?、Q5 .
7.3[+ (dcl 4+1 )7.65 (
broad s 2tl)I R(neat) ;
3220+1655 cIn−’髪
Mass;m/z 2?[] (8M )実施例
1と同様にして、実施例2〜16のヒI゛ロ+シム師誘
導体をfH7こ。NMR (CDC13); δ 1jO (In, 611), 2.20 (
t, 2N) 2.97 (t, 211)
, 2. [i9 (s, 611)? , Q5.
7.3[+ (dcl 4+1)7.65 (
broad s 2tl)I R(neat);
3220+1655 cIn-'Hair Mass; m/z 2? [] (8M) In the same manner as in Example 1, the Hero + Sim derivatives of Examples 2 to 16 were added to fH7.
大1乳λ
■−フェニルー7−1キソヘブタノ
ヒドロキツム酸
褐色粘ちり・う液
I R(neat) ; 16B5.1645 cm
−’Mass;rn/z 235 (M )17
5 (M −CONIION )実施例3
6−(4−クロロフェニル)−6−
ヒドロキシへ十ナノヒドロキリム耐
白色結晶、mpH8〜119℃
?=JMR(DMSO−da ) ; δ1.3
0 (m 、6N)、1.83 (t 、2H
)331 (broad s 2N) 4.40
(t 、111 )7.29 (s 、4H
)
I R(1(Br disk) ; 335
ロ+1655 cm−’−害廁−例」−
5−フェニル−5−ヒ1゛ロキシ
フェニルバレロヒ+fi aキザムgl&白色結晶、
m p 57〜59℃
NMR(DMSO−dに):δ
1.115 <m 、 4H) 、 3.20
(broad s 21)4.4[1(t 、ltl
) 、 7.20 (s 、511 )I R(K
Br disk) ; 3450.2830.161
5cm−’Ma s s ; m/z 209 (
H” )ス薯1i
6−フェニル−6−ヒドロキシ
ヘキサノヒドロキサム酸
赤褐色粘ち量pう液
NMR(DMSO−cls);δ
1.47 <m 、 6H) 、 1.85 (t
、2H)3.42 (broa+:Is 211)
4.38 (t 、1N ) ?、IO(S
、511 )I R(neat ); 32511
.1640 cm−’Mass;m/z 223
(M+ )去6’t 1%l敷
7−フェニル−6−ヒドロキシ
ヘプタノヒドロキサ1.酸
白色結晶 mp 95〜96℃
NMR(cnc+3 ) ; δ
1.40〜1.95 (In 、811.) 2.24
(t 、211 )4.7B (t 、III )
7.41 (S 、5N )I R(KBr d
isk) ; 3200,1625 cIn−’M
a s s ; m/ z 23704” )別W−
例ユ
8−フェニル−8−ヒドロキシ
オクタノヒドロキサ11酸
白色結晶 rnp66〜67℃
NMR(DMSO−da ) ; δ1.30
(m 、1011) 2.05 (t 、2N )4
.55 (t 、ill ) 7.25 (S、
511 )I R(KBr disk) : 324
11,1682 cm−’Ma s s ; rn/
z 251 (M” )実施例日
10−フェニル−10−ヒドロキシ
デカノヒraキサム酸
ン炎黄色I夜
NMR(DMSO−d() ;δ
1.27 (m 、12H) 2.0 (t 、
2H)4.52 (t 、2fl ) 7.26
(s−,511)I R(neat) ; 324
5,16436m−1M a s s ; rn/ z
279 (H+)遺111−
7−(4−メトキシフェニル)−7
一ヒドaキシヘプタノヒドロキザム鈑
I炎褐色液
NMR’(CDCIJ ) ; δ1j7 (+
n 、EIH) 3.73 (s 、3H)4.52
(t 、IH) 6.Bロ 、?、23
(dd 4N )I R(neat) ; 34
50,1645 cm−’Ma s s ; m/ z
253 (M” )寒舶例10
7−(4−ジメチルアミノフェニル)
−7−ヒドロキシヘプタノヒドロキ
サム酸
褐色液体
NMR(口H9O−d、 ) 、 δ1.46
(Ill 、6ft ) 2.63 (s 、[i
ll )4.8? (t 、11+ )
7.20 (broad s 4N )I
R(neat) ; 3200,1640 cm
−’M a s s ; m/ z
293 (N” )実施例11
6−(3−メトキシフェニル)−6
−ヒドロキシヘキサノヒドロキサlい酸褐色層体
NMR(DNSO−dd);δ
3.75 (u+ 、3tl ) 4.78 1r
oad s 2H)6.53〜7.20 (m 、
411 )I R(neat) ; 334
ロ、1650 cm−’Mass;m/z 2!
i3 (M )(M−tlo)K節制12
7−(5−メチルチェニル)−7
−ヒドa+シヘプタノヒドロキナム酸
演褐色液
N M R(DMSO−dd ) ;δ1.2 (
+n 、6N ) 1.90 (t 、2
H)3.45 (s 、211 ) 7.3
0 (s 、2H)I R(neat) ; 33
00,1640 cm−’Ma s s ; m/ z
25? (M” )* 1」]−
6−フェノキシへキツノヒI50キサム酸白色結晶 m
p 69〜70.5℃
NMR(DMSO−dd);δ
1.56 (m 、6tl ) 2.0 (t 、
2H)3.40 (s 、1N ) 3.94
(t 、2H)6.95〜7.31 (m 、5N )
I R(KBr disk) ; 3150,165
0.1241cm−’Ma s s ; m/ z
223 (N+)実施例14
4−クロロフェニルヘキサノ
ヒドロキ・す゛ム酸
渣褐色粘ちI#Iう液
N IJI R(DMSO−dd ) ;δ1.32
(m ’、6N ) 1.9[1(t 、211
)2.5[] (m 、2+1 ) ’
?、20 (S 、4N )I R(neat)
; 1645cm−’Ma s s ; m/
z 241 (M+)U劃」一旦
4−(2−メチル−5−二l・【Iイミダゾリル)ブチ
ロヒドロキリlt 112白色結晶 rnp 194
.5z+96’cNMR(DNSO−dd) ;δ
1.97 <m 、2tl ) 2.22 (S 、
311 )3.1? (broad s III)
、3.76 (t 、211 )8.15(s、IN
)8.59(broads[1)I R(KBr di
sk) ; 3211]、1640,154[1cm
−’尖11拍例16
6−(2−メチル−5−二10.rミダゾリル)ヘキザ
ノヒvロキッム6σ
赤褐色液
N M R(Illイ5o−d、) ; δ2.
23 (8,3H) 2.22 (t 、2H)3.
83 (t 、2N ) 7.10 (s 、IH)
ロ In (broad s 18)I R(
KBr disk) ; 1620cm−’Ma s
s ; m/ z 256 (M” )特許出
願人 日産化字工糸株弐会Large 1 Milk λ ■-Phenyl-7-1xohebbutanohydrochitum Acid Brown sticky fluid IR (neat); 16B5.1645 cm
-'Mass;rn/z 235 (M)17
5 (M-CONIION) Example 3 6-(4-chlorophenyl)-6-hydroxydenananohydrochilim white-resistant crystal, mpH 8-119°C? =JMR(DMSO-da); δ1.3
0 (m, 6N), 1.83 (t, 2H
)331 (broad s 2N) 4.40
(t, 111)7.29 (s, 4H
) I R(1(Br disk); 335
+1655 cm-'-harmful example'-5-phenyl-5-hyroxyphenylvalerohi+fi akizam GL & white crystal,
m p 57-59°C NMR (in DMSO-d): δ 1.115 <m, 4H), 3.20
(broad s 21) 4.4[1(t , ltl
), 7.20 (s, 511)I R(K
Br disk); 3450.2830.161
5cm-'Mass; m/z 209 (
6-phenyl-6-hydroxyhexanohydroxamic acid reddish brown viscosity P fluid NMR (DMSO-cls); δ 1.47 <m, 6H), 1.85 (t
, 2H) 3.42 (broa+:Is 211)
4.38 (t, 1N)? ,IO(S
, 511) I R (neat); 32511
.. 1640 cm-'Mass; m/z 223
(M+) 6't 1% 7-phenyl-6-hydroxyheptanohydroxa 1. Acid white crystal mp 95~96℃ NMR (cnc+3); δ 1.40~1.95 (In, 811.) 2.24
(t, 211) 4.7B (t, III)
7.41 (S,5N)IR(KBrd
isk) ; 3200,1625 cIn-'M
a s s; m/z 23704”) Separate W-
Example 8-phenyl-8-hydroxyoctanohydroxa 11 acid white crystals rnp 66-67°C NMR (DMSO-da); δ1.30
(m, 1011) 2.05 (t, 2N)4
.. 55 (t, ill) 7.25 (S,
511) I R (KBr disk): 324
11,1682 cm-'Mass; rn/
z 251 (M”) Example day 10-phenyl-10-hydroxydecanohyraxamic acid flame yellow I night NMR (DMSO-d(); δ 1.27 (m, 12H) 2.0 (t,
2H) 4.52 (t, 2fl) 7.26
(s-,511)IR(neat); 324
5,16436m-1M ass; rn/z
279 (H+) 111- 7-(4-methoxyphenyl)-7 monohydro-a-oxyheptanohydroxam I flame brown liquid NMR'(CDCIJ); δ1j7 (+
n, EIH) 3.73 (s, 3H) 4.52
(t, IH) 6. Bro,? , 23
(dd 4N)IR(neat); 34
50,1645 cm-'Mass; m/z
253 (M”) Cold Example 10 7-(4-dimethylaminophenyl)-7-hydroxyheptanohydroxamic acid brown liquid NMR (H9O-d, ), δ1.46
(Ill, 6ft) 2.63 (s, [i
ll ) 4.8? (t, 11+)
7.20 (broad s 4N) I
R(neat); 3200,1640 cm
-'M a s s ; m/ z
293 (N”) Example 11 6-(3-methoxyphenyl)-6-hydroxyhexanohydroxalic acid brown layer NMR (DNSO-dd); δ 3.75 (u+, 3tl) 4.78 1r
oads 2H) 6.53-7.20 (m,
411) I R(neat); 334
B, 1650 cm-'Mass; m/z 2!
i3 (M) (M-tlo) K-temperance 12 7-(5-methylchenyl)-7-hydro a+shiheptanohydroquinic acid brown liquor NMR (DMSO-dd); δ1.2 (
+n, 6N) 1.90 (t, 2
H) 3.45 (s, 211) 7.3
0 (s, 2H)IR(neat); 33
00,1640 cm-'Mass; m/z
25? (M”)*1”]-6-phenoxy hexamic acid I50 xamic acid white crystal m
p 69-70.5°C NMR (DMSO-dd); δ 1.56 (m, 6tl) 2.0 (t,
2H) 3.40 (s, 1N) 3.94
(t, 2H) 6.95-7.31 (m, 5N)
IR (KBr disk); 3150,165
0.1241cm-'Mass; m/z
223 (N+) Example 14 4-chlorophenylhexanohydroxamic acid residue brown viscous I#I fluid N IJI R (DMSO-dd); δ1.32
(m', 6N) 1.9[1(t, 211
)2.5[] (m, 2+1)'
? ,20(S,4N)IR(neat)
; 1645cm-'Mass; m/
241 (M+)
.. 5z+96'cNMR (DNSO-dd); δ 1.97 <m, 2tl) 2.22 (S,
311) 3.1? (broads III)
, 3.76 (t , 211 ) 8.15 (s, IN
) 8.59 (broads [1) I R (KBr di
sk) ; 3211], 1640, 154 [1cm
-' 11 cusp Example 16 6-(2-Methyl-5-210.rMidazolyl)hexanohivroquim6σ Reddish-brown liquid NMR (Illi5od,); δ2.
23 (8,3H) 2.22 (t, 2H)3.
83 (t, 2N) 7.10 (s, IH)
In (broad s 18)I R(
KBr disk); 1620cm-'Mas
s; m/z 256 (M”) Patent applicant Nissan Kaji Koitobu Nikai
Claims (2)
Xmを示しくここてRはフェニル基、ピロリル基、チェ
ニル基、イミダゾリル基およびチアゾリル基を示し、X
はハロゲン原子、イハ級アルキル基5 低級アルコキシ
基およびニトロ基を示し5mは0,1または2を示し、
11個のXは同一す/こけ異なることができる。)1
Bは−CH0H−、−CH−、−0−および−CO−
を示し、nは2〜10の整数を示す。〕 ′C表されるヒドロキサム酸誘導体。(1) General formula [1] AB (CH2)n C0NHOHN) [wherein A is R
Xm, where R represents a phenyl group, a pyrrolyl group, a chenyl group, an imidazolyl group, or a thiazolyl group;
represents a halogen atom, an alkyl group 5, a lower alkoxy group and a nitro group; 5m represents 0, 1 or 2;
The 11 X's can be the same/different. )1
B is -CHOH-, -CH-, -0- and -CO-
, and n represents an integer of 2 to 10. ] A hydroxamic acid derivative represented by 'C.
ロリル基、チェニル基、イミダゾリル基およびチアゾリ
ル基を示し、Xはハロゲン原子。 低級アルキル算、低級アルコ+シ基およびニトロ基を示
し1mは0,1談たは2を示し、 rn個のXは同−t
たは異なることができる。)、Bは−CH0’H−、−
CH−、−0−および−co−4示し、nは2〜lOの
Muを示し、Rは低級アルキル基を示す。〕′c表され
るカルボンallエステルとヒドロキシアミノとを反応
させることを特急とする一般式〔1〕 AB (CHI )rI C0NHOH(1)〔式
中、AはRXmを示しくここでRはフェニル基、ピロリ
ル基、チェニル基、イミダゾリル基およびチアゾリル基
を示し、XはハロゲンhW子、低級アルキル基、低級ア
ルコキシ基および二を四基を示し1mは0.1tたは2
を示し1m個のXは同−菫/こは異なることがCきる。 )、Bは−CHOH−+ −crr −、OJ3.
1:rF co−を示し、nは2〜10のU鮫を示す
。〕 ≠表されるヒドロ+サムh■^S体の製造法。(2) General formula [2] AB (CH2)n C0OR (2) [In the formula, A represents RXm, R represents a phenyl group, pyrrolyl group, chenyl group, imidazolyl group, and thiazolyl group, and X represents halogen atom. Lower alkyl arithmetic, lower alkoxy group and nitro group, 1m indicates 0, 1 or 2, rn number of X is the same -t
or can be different. ), B is -CH0'H-, -
CH-, -0- and -co-4, n represents Mu of 2 to 1O, and R represents a lower alkyl group. [1] AB (CHI ) rI C0NHOH (1) [In the formula, A represents RXm, and R is phenyl] group, pyrrolyl group, chenyl group, imidazolyl group, and thiazolyl group, X represents a halogen hW atom, lower alkyl group, lower alkoxy group, and 2-4 group;
, and 1m X's are the same - violet/ko are different. ), B is -CHOH-+ -crr-, OJ3.
1: rF co-, n represents 2 to 10 U sharks. ] ≠Hydro+Sam h■^Production method of S form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57157049A JPS5946244A (en) | 1982-09-09 | 1982-09-09 | Hydroxamic acid derivative and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57157049A JPS5946244A (en) | 1982-09-09 | 1982-09-09 | Hydroxamic acid derivative and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5946244A true JPS5946244A (en) | 1984-03-15 |
Family
ID=15641073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57157049A Pending JPS5946244A (en) | 1982-09-09 | 1982-09-09 | Hydroxamic acid derivative and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5946244A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01139297A (en) * | 1987-11-26 | 1989-05-31 | Mitsubishi Heavy Ind Ltd | Ink stain prevention on roller surface of printing machine |
US4861798A (en) * | 1986-12-29 | 1989-08-29 | Bristol-Myers Company | Lipoxygenase inhibitory compounds |
US5036157A (en) * | 1986-03-11 | 1991-07-30 | Burroughs Wellcome Co. | Aryl derivatives |
US5804601A (en) * | 1995-04-10 | 1998-09-08 | Takeda Chemical Industries, Ltd. | Aromatic hydroxamic acid compounds, their production and use |
WO1998055449A1 (en) * | 1997-06-06 | 1998-12-10 | The University Of Queensland | Hydroxamic acid compounds having anticancer and anti-parasitic properties |
US6770644B1 (en) | 1999-09-24 | 2004-08-03 | Ono Pharmaceuticals Co., Ltd. | Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
-
1982
- 1982-09-09 JP JP57157049A patent/JPS5946244A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5036157A (en) * | 1986-03-11 | 1991-07-30 | Burroughs Wellcome Co. | Aryl derivatives |
US4861798A (en) * | 1986-12-29 | 1989-08-29 | Bristol-Myers Company | Lipoxygenase inhibitory compounds |
JPH01139297A (en) * | 1987-11-26 | 1989-05-31 | Mitsubishi Heavy Ind Ltd | Ink stain prevention on roller surface of printing machine |
US5804601A (en) * | 1995-04-10 | 1998-09-08 | Takeda Chemical Industries, Ltd. | Aromatic hydroxamic acid compounds, their production and use |
WO1998055449A1 (en) * | 1997-06-06 | 1998-12-10 | The University Of Queensland | Hydroxamic acid compounds having anticancer and anti-parasitic properties |
US6770644B1 (en) | 1999-09-24 | 2004-08-03 | Ono Pharmaceuticals Co., Ltd. | Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cope et al. | The Rearrangement of Allyl Groups in Three-Carbon Systems. I. | |
CZ287842B6 (en) | Process for preparing 17beta-(N-tert-butylcarbonyl)-4-aza-5alph-androst-1-en-3-one | |
JPS5946244A (en) | Hydroxamic acid derivative and its preparation | |
JPS61180728A (en) | Production of secondary amine compound | |
US2648708A (en) | Benzamide derivatives | |
DE3314029C2 (en) | ||
JPH0373543B2 (en) | ||
JPS60237041A (en) | Preparation of 3-propionylsalicylic acid derivative | |
JPH037245A (en) | Preparation of 2-oxo-3-aromatic carboxylic acid derivative | |
JPS62207232A (en) | Production of 2-methylazulene compound | |
US2971022A (en) | Method of ring cleavage of 2-furoic acid | |
JPH072678B2 (en) | Process for producing 2-cyclopentenone derivative | |
JP2022502413A (en) | Synthetic method for the preparation of alkoxymethylene-benzoylacetonitrile | |
JPS6160673A (en) | Preparation of guanidinothiazole derivative | |
SU973526A1 (en) | Process for producing 1,1-bis(alcylamino)ketones | |
JPS61186359A (en) | Production of formamide derivative | |
US1977561A (en) | Secondary-butyl-carbinyl ethyl | |
JPS6121949B2 (en) | ||
JPS58198478A (en) | Preparation of alpha-methylene lactone | |
JP2004277386A (en) | 2-(dichlorophenyl)-4-methyl-5-phenylimidazole compound | |
SU450403A3 (en) | Method for preparing substituted thioureidobenzene | |
KR800000623B1 (en) | Method of producing indan derivatives | |
JP2022502415A (en) | Synthetic method for the preparation of hydrazine compounds | |
JPH08333327A (en) | Production of 1,4-cross-linked cyclohexane-based carboxylic acid derivative | |
JPS5821661A (en) | Sulfonate derivative and its preparation |